DGAP-News: Centrotec SE
/ Key word(s): Delisting
- Corporate News - Correction of english version Brilon: Today, Tuesday the 12th of January 2021, the Frankfurt Stock Exchange has informed CENTROTEC SE (ISIN DE0005407506), that the application of CENTROTEC SE for revocation of the listing of the shares of CENTROTEC SE for trading in the regulated market of the Frankfurt Stock Exchange has been approved and granted. The Frankfurt Stock Exchange has ordered that this decision shall be executed without delay (sofortige Vollziehung). According to the stipulations of the stock exchange rules of the Frankfurt Stock Exchange (Börsenordnung) the revocation of the listing on the stock exchange will become effective as of January 15, 2021, end of day. After that date CENTROTEC shares can no longer be traded on the Frankfurt Stock Exchange. The voluntary public delisting purchase offer by Mr. Guido Krass can be accepted by CENTROTEC shareholders until its end on January 15, 2021. CENTROTEC SE Contact person For further information, contact:
12.01.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Centrotec SE |
Am Patbergschen Dorn 9 | |
59929 Brilon | |
Germany | |
Phone: | +49 (0)2961 96631-0 |
Fax: | +49 (0)2961 96631-100 |
E-mail: | ir@centrotec.de |
Internet: | www.centrotec.de |
ISIN: | DE0005407506 |
WKN: | 540750 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1160217 |
End of News | DGAP News Service |
|
1160217 12.01.2021
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.